Royal Bank of Canada
SNOA icon

Royal Bank of Canada’s Sonoma Pharmaceuticals SNOA Stock Holding History

Royal Bank of Canada’s Portfolio SNOA Stock Details SNOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-26
Closed – – 7226
2024
Q3 		$0 Buy
+26
New +$133 ﹤0.01% 7388
2020
Q1 		– Hold
0
– – – 6993
2019
Q4 		– Hold
0
– – – 7093
2018
Q2 		– Hold
0
– – – 6745
2018
Q1 		– Hold
0
– – – 6755
2017
Q4 		– Hold
0
– – – 6853
2017
Q3 		– Hold
0
– – – 6957
2016
Q4 		– Sell
-1
Closed -$1K – 6769
2016
Q3 		$1K Buy
+1
New +$751 ﹤0.01% 6303
2014
Q3 		– Hold
0
– – – 6117
2014
Q2 		– Hold
0
– – – 6117
2014
Q1 		– Hold
0
– – – 6129

Other funds holding SNOA

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

Royal Bank of Canada's SNOA Position: Q4 2024 in Review

Royal Bank of Canada sold out of Sonoma Pharmaceuticals (SNOA) in Q4 2024, closing a stake of 26 shares.

Royal Bank of Canada first reported a position in SNOA in Q3 2016 and held it in 2 quarters. The position peaked at $1K in Q3 2016. 9 funds tracked by Wall St. Rank hold SNOA as of Q4 2024.

  • Royal Bank of Canada reported no remaining Sonoma Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 26 Sonoma Pharmaceuticals shares in Q4 2024.
  • Royal Bank of Canada first reported a position in Sonoma Pharmaceuticals in Q3 2016 and held it in 2 quarters.
  • Royal Bank of Canada's Sonoma Pharmaceuticals position peaked at $1K in Q3 2016.
  • 9 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q4 2024.

Based on Royal Bank of Canada's 13F filing for Q4 2024, filed 14 Feb 2025.